Business Context and Reporting Period
This Form 8-K reports on the 2021 Annual Meeting of Stockholders held by MacroGenics, Inc. on May 13, 2021. The meeting addressed three proposals regarding director elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 53,504,495 shares were present or represented by proxy, representing approximately 89% of the 59,967,099 outstanding shares entitled to vote. All three proposals were approved:
- Proposal 1 (Director Election): All three Class II nominees (Kenneth Galbraith, Scott Jackson, and David Stump, M.D.) were elected for three-year terms.
- Proposal 2 (Auditor Ratification): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2021.
- Proposal 3 (Executive Compensation): Stockholders approved, on an advisory basis, the compensation of named executive officers.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the specific vote counts for each director nominee to assess shareholder support levels.
- Confirm the ratification of Ernst & Young LLP as the independent auditor for the 2021 fiscal year.
- Review the definitive proxy statement filed on April 2, 2021, for detailed executive compensation data referenced in Proposal 3.